Oh M, Alkhushaym N, Fallatah S, Althagafi A, Aljadeed R, Alsowaida Y, et al
This doesnt make the benefits less meaningful, but it does help clarify where theyre coming from
Glucagon-like peptide-1 synthetic analogs: new therapeutic agents for use in the treatment of diabetes mellitus
Reported side effects include mild drowsiness, headache, and injection site reactions
Employer coalitions could pool risk, subscription models may spread costs more predictably, and outcomes-based contracts could tie payments to real-world health improvements
Despite working quickly on insulin, it may take time to feel the effects of Tirzepatide